The experts group stats & facts
Experts
Countries
Publications
Recent updates
The Therapeutic Potential of Myo-Inositol in Managing Patients with Respiratory Diseases
Authors: Quecchia C, Vianello A.
Unexpected effects of treating insulin-resistant obese women with high-dose D-chiro-inositol: opening Pandora’s box
Authors: Sabrina Basciani, Maurizio Nordio, Maria Letizia Spizzichini and Lucio Gnessi
A retrospective study “myo-inositol is a cost-saving strategy for controlled ovarian stimulation in non-polycystic ovary syndrome art patients.”
Authors: Aragona C, Russo M, Myers SH, Espinola MSB, Bilotta G, Unfer V.
Gestational diabetes mellitus and polycystic ovary syndrome, a position statement from EGOI-PCOS
Authors: Quaresima P, Myers SH, Pintaudi B, D’Anna R, Morelli M and Unfer V
Delphi consensus on the diagnostic criteria of polycystic ovary syndrome
Authors: Fabio Facchinetti, Alessandra Gambineri, Gianluca Aimaretti, Alberto Ferlin, Antonio Simone Laganà, Paolo Moghetti, Mario Montanino Oliva, Vittorio Unfer, Annamaria Colao
Murine Models and Human Cell Line Models to Study Altered Dynamics of Ovarian Follicles in Polycystic Ovary Syndrome
Authors: Arturo Bevilacqua, Cristiano Giuliani, Giovanna Di Emidio, Samuel H Myers, Vittorio Unfer, and Carla Tatone

Empowering Global Health: EGOI-PCOS Roundtable at the WHO
Authors: EGOI Members
Myo-Inositol and Its Derivatives: Their Roles in the Challenges of Infertility
Authors: Martina Placidi, Giovanni Casoli, Carla Tatone, Giovanna Di Emidio and Arturo Bevilacqua

EGOI-PCOS Joins FISM as Supporting Affiliate Member to Strengthen Women’s Health Research
Authors: EGOI Members

EGOI-PCOS attended the SIGO Congress in Florence
Authors: EGOI Members